This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Toth, M. J. Articles by Matthews, D. E. Search for Related Content PubMed PubMed Citation Articles by Toth, M. J. Articles by Matthews, D. E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Failure Social Bookmarking                         What's this?

Whole-Body Protein Metabolism in Chronic Heart Failure: Relationship to Anabolic and Catabolic Hormones

From the Department of Medicine, University of Vermont, Burlington, Vermont

Correspondence: Michael J. Toth, PhD, Health Science Research Facility 126 B, 149 Beaumont Ave., University of Vermont, Burlington, VT 05405. Electronic mail may be sent to michael.toth{at}uvm.edu.

Background: Patients with chronic heart failure frequently experience profound wasting during the course of the disease, a condition termed cardiac cachexia. Although protein is the primary structural and functional component of most tissues, few studies have examined the effect of heart failure on protein metabolism. Moreover, no study has assessed the relationship of protein turnover to hormonal alterations thought to promote cachexia. Thus, our goal was to determine if whole-body protein metabolism is altered in heart failure patients and to assess the relationship of protein kinetics to circulating levels of anabolic and catabolic hormones. Methods:We measured whole-body protein metabolism using ¹³C-leucine, body composition, and circulating anabolic and catabolic hormone levels in 10 patients with chronic heart failure and 11 elderly controls. Results: No differences in leucine rate of appearance, oxidation, or nonoxidative disposal were noted between heart failure patients and controls. However, in a subgroup of patients characterized by increased resting energy expenditure for their metabolic body size (n = 4; 20% above that predicted from fat-free mass), leucine rate of appearance (mean ± SE; 146 ± 6 µmol/min), an index of protein breakdown, tended to be higher compared with patients with normal resting energy expenditure (n = 5; 120 ± 8 µmol/min) and controls (127 ± 4 µmol/min; p = .06). Alterations in anabolic/catabolic hormone balance did not explain increased protein breakdown in this subgroup, and no correlations were found between hormone levels and protein breakdown in the heart failure group as a whole. In contrast, increased circulating interleukin-6 soluble receptor (r = 0.829; p < .01) and reduced insulin-like growth factor-I (r =–.751; p < .05) levels were related to greater rates of leucine oxidation in heart failure patients. Conclusion: Our results demonstrate that, although increased protein turnover is not a generalized feature of heart failure, there is a subgroup of patients characterized by resting hypermetabolism and increased protein breakdown. Moreover, hormonal alterations related to the heart failure syndrome were related to increased protein oxidation.

Journal of Parenteral and Enteral Nutrition, Vol. 30, No. 3, 194-201 (2006)
DOI: 10.1177/0148607106030003194


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Aquilani, C. Opasich, A. Gualco, M. Verri, A. Testa, E. Pasini, S. Viglio, P. Iadarola, O. Pastoris, M. Dossena, et al. Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure Eur J Heart Fail, November 1, 2008; 10(11): 1127 - 1135. [Abstract] [Full Text] [PDF]